Government and regulatory requirements are designed to promote safer and more efficient patient care, but healthcare organizations often struggle to keep up with the changing mandates from the state and federal government. Medi-Span supports customers in complying with these mandates by conveniently providing the latest data needed to meet the regulatory requirements.
Medi-Span provides data needed to address state and federal government initiatives. Wolters Kluwer continuously monitors government regulatory requirements to help you stay ahead of any changes or updates that need to be implemented within your workflow.
Medi-Span provides access to important drug pricing data from the Centers for Medicare & Medicaid Services (CMS) as soon as the government makes it available, allowing you to establish and compare pricing methodologies for state Medicaid and beyond.
Medi-Span helps you meet mandatory U.S. compliance requirements for controlled substances and support quality assurance programs. This is important due to ongoing increases in verification, monitoring, and reporting requirements for controlled substances.
Medi-Span provides data to support other requirements related to interoperability, monitoring, and more.
Learn more about our core drug data solutions, data solutions for drug attributes, and interoperability mapping solutions that can support and help you pursue regulatory requirements.
Wolters Kluwer clinical drug information leaders on the Medi-Span development team are actively involved in decision making and providing recommendations for nationally recognized industry regulation and standard organizations, such as PQA, ONC, Surescripts, ASHP, APhA, and NCPDP.
Our solutions have been trusted across the healthcare continuum for over 150 years!
